Intuitive Surgical Inc
Closed
SectorHealthcare
369.03 2.46
Overview
Share price change
24h
Min
368.02
Max
371.86
Income | 1.7M 823M |
|---|---|
Sales | 122M 2.9B |
P/E Sector Avg | 42.005 56.597 |
EPS | 2.8 |
Profit margin | 28.462 |
Employees | 17,021 |
EBITDA | 34M 1.2B |
Next Earnings | 20 Oct 2026 |
|---|
Market Cap | -13B 131B |
|---|---|
Previous open | 366.57 |
Previous close | 369.03 |
News Sentiment
By Acuity
19%
81%
25 / 339 Healthcare
Intuitive Surgical Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Intuitive Surgical Inc Forecast
Sentiment
By Acuity
25 / 339 Healthcare
News Sentiment
Very Strong Bullish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Intuitive Surgical Inc
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.